Neurophysiological markers of emotional stimuli processing in schizophrenia and schizoaffective disorder
- Authors: Spektor V.A.1, Mnatsakanyan E.V.2, Spektor E.D.2, Trushin A.A.1, Davydova A.S.1, Shmukler A.B.1
-
Affiliations:
- V. Serbsky National Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
- Issue: Vol 6, No 4 (2025)
- Pages: 47-57
- Section: RESEARCH
- URL: https://journals.rcsi.science/2712-7672/article/view/368182
- DOI: https://doi.org/10.17816/CP15717
- ID: 368182
Cite item
Full Text
Abstract
BACKGROUND: Schizophrenia and schizoaffective disorder significantly affect the cognitive and emotional functioning of patients. Establishing reliable neurophysiological markers as objective assessment tools can increase diagnostic accuracy and improve outcomes.
AIM: To identify neurophysiological correlates of impaired facial expression perception in patients with schizophrenia and schizoaffective disorder, and to develop a diagnostic model based on these markers.
METHODS: The study included 86 participants: 26 with schizophrenia, 26 with schizoaffective disorder, and 34 healthy volunteers. The study recorded electrical brain activity in response to stimuli with faces showing happy, fearful, and neutral expressions using a 128-channel electroencephalographic system. The P100, N170, P200, and P300 components were analyzed. Logistic regression and ROC analysis were used to develop a diagnostic model.
RESULTS: We developed a diagnostic model that differentiates patients with schizophrenia and schizoaffective disorder from healthy participants. The model achieved 73.3% sensitivity and 80% specificity.
CONCLUSION: The findings demonstrate the diagnostic value of evoked potentials and support their application as a supplementary objective diagnostic tool.
About the authors
Valeriy A. Spektor
V. Serbsky National Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: spektor.v@serbsky.ru
ORCID iD: 0000-0002-3521-5453
SPIN-code: 9154-8092
Cand. Sci (Med.), Researcher, Department of Psychotic Spectrum Disorders
Russian Federation, MoscowElena V. Mnatsakanyan
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Email: spektor.v@serbsky.ru
ORCID iD: 0000-0003-3407-1977
SPIN-code: 2627-4145
Cand. Sci (Biolog.), Senior Researcher, Laboratory of Human Higher Nervous Activity
Russian Federation, MoscowEkaterina D. Spektor
Email: spektor.v@serbsky.ru
ORCID iD: 0000-0003-0714-9476
SPIN-code: 1760-9113
Cand. Sci (Med.), independent investigator
Russian FederationAlexey A. Trushin
V. Serbsky National Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation
Email: spektor.v@serbsky.ru
ORCID iD: 0009-0003-7064-4055
SPIN-code: 8508-4556
Cand. Sci (Med.), Junior Researcher, Department of Psychotic Spectrum Disorders
Russian Federation, MoscowAnna S. Davydova
V. Serbsky National Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation
Email: spektor.v@serbsky.ru
ORCID iD: 0009-0002-3028-6241
SPIN-code: 1845-4071
Cand. Sci (Med.), Head of the Clinical Department
Russian Federation, MoscowAlexander B. Shmukler
V. Serbsky National Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation
Email: spektor.v@serbsky.ru
ORCID iD: 0000-0002-7187-9361
SPIN-code: 4932-7980
Dr. Sci (Med.), Professor, Deputy Director General for Research, Acting Director, Moscow Research Institute of Psychiatry, a branch of the V. Serbsky National Medical Research Centre of Psychiatry and Narcology of the Ministry of Health of the Russian Federation
Russian Federation, MoscowReferences
- Beck AT, Ward CH, Mendelson M, et al. Reliability of psychiatric diagnoses: 2. A study of consistency of clinical judgments and ratings. Am J Psychiatry. 1962;119(4):351–357. doi: 10.1176/ajp.119.4.351
- Copeland JR, Kelleher MJ, Kellett JM, et al. Diagnostic Differences in Psychogeriatric Patients in London and New York: United Kingdom – United States Diagnostic Project. Can Psychiatr Assoc J. 1974;19(3):267–271. doi: 10.1177/070674377401900305
- Rocha Neto H, Moreira ALR, Hosken L, et al. Inter-Rater Reliability between Structured and Non-Structured Interviews Is Fair in Schizophrenia and Bi-polar Disorders – A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2023;13(3):526. doi: 10.3390/diagnostics13030526
- Cai XL, Xie DJ, Madsen KH, et al. Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data. Hum Brain Mapp. 2020;41(1):172–184. doi: 10.1002/hbm.24797
- Mallard TT, Karlsson Linnér RK, Grotzinger AD, et al. Multivariate GWAS of psychiatric disorders and their cardinal symptoms reveal two dimensions of cross-cutting genetic liabilities. Cell Genomics. 2022;2(6):100140. doi: 10.1016/j.xgen.2022.100140
- Berk M. Biomarkers in psychiatric disorders: status quo, impediments and facilitators. World Psychiatry. 2023;22(2):174–176. doi: 10.1002/wps.21071
- Fedotov IA, Shustov DI. [The meaning of event-related potentials P50 and P300 in diagnosis and therapy of psychosis: a systematic review of meta-analyses]. Social’naja i klinicheskaja psihiatrija. 2024;34(1):78–86. Russian. doi: 10.34757/0869-4893.2024.34.1.007
- Fedotov IA, Shustov DI, Kudinov DD, et al. [Cognitive evoked potentials for sensory filtering (n100, p200), semantic phrase processing (n400), performance monitoring and feedback, and facial expression processing and stead-state auditory evoked potentials in psychosis: a systematic review of meta-analyses]. Social’naja i klinicheskaja psihiatrija. 2025;35(1):53–61. Russian.
- Karjakina MV, Shmukler AB. [Cognitive deficit geterogenecity in patients with schizophrenia and schizophrenic spectrum disorders]. Social’naja i klinicheskaja psihiatrija. 2021;31(3):13–20. Russian.
- Murashko AA. [Neurophysiological peculiarities of face perception in schizophrenia spectrum disorders]. Social’naja i klinicheskaja psihiatrija. 2018;28(3):87–91. Russian.
- Gao Z, Zhao W, Liu S, et al. Facial Emotion Recognition in Schizophrenia. Front Psychiatry. 2021;12:633717. doi: 10.3389/fpsyt.2021.633717
- Mewton P, Dawel A, Miller EJ, et al. Meta-analysis of Face Perception in Schizophrenia Spectrum Disorders: Evidence for Differential Impairment in Emotion Face Perception. Schizophr Bull. 2024;51(1):17–36. doi: 10.1093/schbul/sbae130
- Zhirmunskaja EA, Losev VS. [Systems of description and classification of human electroencephalograms]. Moscow: Nauka; 1984. Russian.
- Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261
- Loewy RL, Bearden CE, Johnson JK, et al. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res. 2005;77(2-3):141–149. doi: 10.1016/j.schres.2005.03.007
- Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–583. doi: 10.1016/s0006-3223(02)01866-8
- Annett M. A classification of hand preference by association analysis. Br J Psychol. 1970;61(3):303–321. doi: 10.1111/j.2044-8295.1970.tb01248.x
- Hohlov NA, Burova AV. [Modification of the questionnaire by M. Annett to assess functional asymmetry: standardization and psychometric characteristics]. Aprobacija. 2014;(8):65–73. Russian.
- Leucht S, Samara M, Heres S, et al. Dose Equivalents for Antipsychotic Drugs: The DDD Method. Schizophr Bull. 2016;42(Suppl 1):S90–S94. doi: 10.1093/schbul/sbv167
- Lundqvist D, Flykt A, Öhman A. The karolinska directed emotional faces. Stockholm: Karolinska Institute; 1998.
- Goeleven E, De Raedt R, Leyman L, et al. The Karolinska Directed Emotional Faces: A validation study. Cognition & Emotion. 2008;22(6):1094–1118. doi: 10.1080/02699930701626582
- Kebets V, Favre P, Houenou J, et al. Fronto-limbic neural variability as a transdiagnostic correlate of emotion dysregulation. Transl Psychiatry. 202121;11(1):545. doi: 10.1038/s41398-021-01666-3
- Gangl N, Conring F, Federspiel A, et al. Resting-state perfusion in motor and fronto-limbic areas is linked to diminished expression of emotion and speech in schizophrenia. Schizophrenia (Heidelb). 2023;9(1):51. doi: 10.1038/s41537-023-00384-7
- Pinkham AE, Penn DL, Perkins DO, et al. Emotion perception and social skill over the course of psychosis: A comparison of individuals “at-risk” for psychosis and individuals with early and chronic schizophrenia spectrum illness. Cogn Neuropsychiatry. 2007;12(3):198–212. doi: 10.1080/13546800600985557
- Fakra E, Salgado-Pineda P, Delaveau P, et al. Neural bases of different cognitive strategies for facial affect processing in schizophrenia. Schizophr Res. 2008;100(1-3):191–205. doi: 10.1016/j.schres.2007.11.040
- Spektor VA, Mnacakanjan EV, Spektor ED, et al. [Schizophrenia classification based on neurophysiological measures]. Social’naja i klinicheskaja psihiatrija. 2024;34(3):23–32. Russian.
- Campanella S, Montedoro C, Streel E, et al. Early visual components (P100, N170) are disrupted in chronic schizophrenic patients: an event-related potentials study. Neurophysiol Clin. 2006;36(2):71–78. doi: 10.1016/j.neucli.2006.04.005
- Horan WP, Hajcak G, Wynn JK, et al. Impaired emotion regulation in schizophrenia: evidence from event-related potentials. Psychol Med. 2013;43(11):2377–2391. doi: 10.1017/s0033291713000019
- Hamilton HK, Mathalon DH, Ford JM. P300 in schizophrenia: Then and now. Biol Psychol. 2024;187:108757. doi: 10.1016/j.biopsycho.2024.108757
- Saha A, Park S, Geem ZW, et al. Schizophrenia Detection and Classifi-cation: A Systematic Review of the Last Decade. Diagnostics (Basel). 2024;14(23):2698. doi: 10.3390/diagnostics14232698
- Horley K, Gonsalvez C, Williams L, et al. Event-related potentials to threat-related faces in schizophrenia. Int J Neurosci. 2001;107(1-2):113–130. doi: 10.3109/00207450109149761
- Turetsky BI, Dress EM, Braff DL, et al. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: clinical and socio-demographic modulators in COGS-2. Schizophr Res. 2015;163(1-3):53–62. doi: 10.1016/j.schres.2014.09.024
Supplementary files

